In-Vitro Diagnostic Substance Manufacturing Industry

NAICS: 325413

For additional companies see the Pharmaceutical & Medicine Manufacturing Industry

In-Vitro Diagnostic Substance Manufacturing Market Share: Largest Companies in the In-Vitro Diagnostic Substance Manufacturing Industry

Company	Headquarters	Revenue ($ MM)
CUE HEALTH	San Diego, CA	100
ACCESS BIO	Somerset, NJ	24
AALTO SCIENTIFIC	Eatonton, GA	17
LUMINOSTICS	Fremont, CA	7
SDIX	Newark, DE	4
SEDIA BIOSCIENCES	Beaverton, OR	3
ZEPTO LIFE TECHNOLOGY	Saint Paul, MN	3
ARLINGTON SCIENTIFIC	Springville, UT	2
BIOPOOL US	Jamestown, NY	2
DIAMEDIX	Miami Lakes, FL	2
QUANSYS BIOSCIENCES	Logan, UT	2
AGDIA	Elkhart, IN	1
QUANTIMETRIX	Redondo Beach, CA	1
BIODIRECTION	Southborough, MA	1
RASILIENT SYSTEMS	Santa Clara, CA	1
UH-OH LABS	Santa Clara, CA	1
NVIGEN	Campbell, CA	1
BIOLOG-ID	Alpharetta, GA	0
BIG EYE DIAGNOSTICS	San Diego, CA	0

This is a list of the largest companies active in the In-Vitro Diagnostic Substance Manufacturing industry. This differs from market share in the following example: One business with revenues of $100 million generates 10% of its business from the In-Vitro Diagnostic Substance Manufacturing industry. A second firm, with revenues of $20 million, generates all of its business from this industry. In our list, we show the businesses having revenues of $100 million and $20 million, respectively. However, the market share would compare the $10 million in industry-specific revenue to the $20 million: the second company has twice the market share even though it is "smaller" in size.

Growth: Fastest Growing In-Vitro Diagnostic Substance Manufacturing Companies

A list of competitors in the In-Vitro Diagnostic Substance Manufacturing industry that are rapidly expanding. Businesses may grow organically or through acquisition. Typically, small or midsized companies are in "growth" mode and can expand more rapidly. However, large businesses may have the strategy and financial capabilities to scale rapidly. Businesses that employ a "roll-up" strategy make multiple acquisitions of smaller businesses to form a single large corporation that controls a greater market share than its competitors and benefits from economies of scale.

View List


View Full List

Small Business Financing

Small businesses that have received financing may expand soon. Financing may be required for capital-intensive investments, such as real estate or equipment purchases. In-Vitro Diagnostic Substance Manufacturing businesses may use the financing to cover startup expenses or the costs of hiring new employees. Loans differ from equity investments in the level of risk that is expected: loans frequently have collateral either directly or implicitly through the business or the owners that ensure repayment. Equity investment has the possibility for much greater returns, but offers no guarantee the principle will be repaid. Convertible securities combine the two concepts, but is used by private-equity firms rather than main street startups.

View List

Venture Funding

These In-Vitro Diagnostic Substance Manufacturing companies are actively raising capital from venture capital firms, private equity, or other investors. Businesses with venture funding generally have higher growth prospects, either through bringing new concepts to market, using innovative business practices, or savvy management.

View List